Velarion · Company Intelligence
Compensation Brief
Fiscal year 2025 · Filings through 2026-10-05

Cencora (COR)

CEO Robert Mauch was paid $18,256,227 in fiscal year 2025, ↑ up 97.3% from fiscal year 2024, the 39th percentile of its disclosed peer group (SEC filing 0001628280-26-003061 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$18,256,227 ↑
Robert Mauch total, FY2025
39th
CEO pay percentile vs peers
198:1
CEO-to-median pay ratio
92.98%
Say-on-pay support, latest vote

Track this company's pay every filing: join the Pro seat waitlist

Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year

A confirmation now and one email when Pro opens, and nothing else. Privacy

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Robert Mauch (President and Chief Executive Officer), FY2025 total compensation $18,256,227 (base salary $1,350,000) [exec_comp, SEC accession 0001628280-26-003061, filed 2026-01-22]

Answered within 24 hours, every figure cited to its SEC filing. If our database cannot answer your question, you are refunded automatically.

COR's next annual pay disclosure, estimated January 21, 2027.est. Filing ↗

01

Summary Compensation Table — fiscal year 2025

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Robert Mauch$1,350,000$0$12,000,218$0$4,283,213$0$622,796$18,256,227
President and Chief Executive Officer
Steven Collis1,000,00006,000,23001,813,0000867,0059,680,235
Executive Chairman
James Cleary926,13703,800,00001,679,0870116,5036,521,727
Executive Vice President and Chief Financial Officer
Elizabeth Campbell769,20502,900,16001,394,5700112,7335,176,668
Executive Vice President and Chief Legal Officer
Silvana Battaglia664,84901,700,45401,205,372092,7183,663,393
Executive Vice President and Chief Human Resources Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY2024→2025
Robert Mauch$18,256,227$9,253,192$7,697,850↑ +9,003,035
Steven Collis9,680,23518,475,17117,511,240↓ −8,794,936
James Cleary6,521,7279,003,9605,449,373↓ −2,482,233
Elizabeth Campbell5,176,6687,669,0644,027,232↓ −2,492,396
Silvana Battaglia3,663,3935,320,2122,976,306↓ −1,656,819

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

You have just read Cencora's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper COR reports.

We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.

How we handle your data → Privacy

Companies that benchmark against COR
12 companies name COR as a compensation peer

Each company listed discloses COR in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named COR in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.

01c

Board of directors

One page per director: the seat, the committees and the fee table, read for one person at a time.

DirectorRoleFY2025 total
D. Mark DurcanChair of the Board$375,217
Dennis M. NallyIndependent Director$345,706
Ellen G. CooperIndependent Director—
Frank K. ClyburnIndependent Director$396,436
Kathleen W. HyleFormer director (through FY2025)$60,000
Lauren M. TylerIndependent Director$360,940
Lon R. GreenbergIndependent Director$330,225
Lorence H. Kim, M.DIndependent Director$330,225
Lori J. RyerkerkIndependent Director$192,390
Ornella BarraFormer director (through FY2025)—
Redonda G. Miller, M.DIndependent Director$385,225
Richard W. GochnauerFormer director (through FY2025)$50,000
Werner BaumannIndependent Director$383,095
02

Equity transactions since the proxy statement was filed

Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Lauren M. TylerDirector2026-01-30A84$359$30,174CommonForm 4 ↗
Dennis M. NallyDirector2026-01-30A9835935,204CommonForm 4 ↗
Ellen G. CooperDirector2026-01-30A6935924,786CommonForm 4 ↗
Ellen G. CooperDirector2026-01-30A6635923,709CommonForm 4 ↗
Robert P. MauchDirector2026-02-18D1,333359479,160CommonForm 4 ↗
Robert P. MauchDirector2026-02-20A3,76286323,871CommonForm 4 ↗
Robert P. MauchDirector2026-02-20D3,76200Derivative, Class A CommonForm 4 ↗
Robert P. MauchDirector2026-02-20D3,7623591,350,332CommonForm 4 ↗
Lori J. RyerkerkDirector2026-03-05A557359200,119CommonForm 4 ↗
Redonda MillerDirector2026-03-05A557359200,119CommonForm 4 ↗
D. Mark DurcanDirector2026-03-05A905359325,148CommonForm 4 ↗
Werner BaumannDirector2026-03-05A557359200,119CommonForm 4 ↗
Lauren M. TylerDirector2026-03-05A557359200,119CommonForm 4 ↗
Dennis M. NallyDirector2026-03-05A557359200,119CommonForm 4 ↗
Ellen G. CooperDirector2026-03-05A557359200,119CommonForm 4 ↗
Frank K. ClyburnDirector2026-03-05A557359200,119CommonForm 4 ↗
Lorence H. KimDirector2026-03-05A557359200,119CommonForm 4 ↗
Lon R. GreenbergDirector2026-03-05A557359200,119CommonForm 4 ↗
James ClearyChief Financial Officer2026-03-11D12,62300Derivative, Class A CommonForm 4 ↗
Elizabeth CampbellExecutive Vice President2026-03-11D12,62300Derivative, Class A CommonForm 4 ↗
Silvana BattagliaExecutive Vice President2026-03-11D8,41500Derivative, Class A CommonForm 4 ↗
Silvana BattagliaExecutive Vice President2026-03-11D3,6733501,286,652CommonForm 4 ↗
Elizabeth CampbellExecutive Vice President2026-03-11A12,62300CommonForm 4 ↗
Silvana BattagliaExecutive Vice President2026-03-11A8,41500CommonForm 4 ↗
James ClearyChief Financial Officer2026-03-11A12,62300CommonForm 4 ↗
James ClearyChief Financial Officer2026-03-11D5,4093501,894,773CommonForm 4 ↗
Elizabeth CampbellExecutive Vice President2026-03-11D5,8423502,046,453CommonForm 4 ↗
Lazarus KrikorianSVP & Chief Accounting Officer2026-04-01A3,93600Derivative, Class A CommonForm 4 ↗
Dennis M. NallyDirector2026-05-01A11630435,264CommonForm 4 ↗
Lauren M. TylerDirector2026-05-01A9930430,096CommonForm 4 ↗
Ellen G. CooperDirector2026-05-01A9930430,096CommonForm 4 ↗
D. Mark DurcanDirector2026-05-28A4,0002661,065,040CommonForm 4 ↗
D. Mark DurcanDirector2026-06-18A4,0002741,096,760CommonForm 4 ↗
Lauren M. TylerDirector2026-06-22A550270148,627CommonForm 4 ↗
Eva C. BorattoChief Financial Officer2026-06-29A21,304——Derivative, Class A CommonForm 4 ↗
Elizabeth CampbellExecutive Vice President2026-06-30A49.8924112,000CommonForm 4 ↗
Silvana BattagliaExecutive Vice President2026-06-30A58.224114,000CommonForm 4 ↗
Ellen G. CooperDirector2026-07-31A9731130,200CommonForm 4 ↗
Dennis M. NallyDirector2026-07-31A11331135,181CommonForm 4 ↗
Lauren M. TylerDirector2026-07-31A9731130,200CommonForm 4 ↗
Elizabeth CampbellExecutive Vice President2026-08-24D11,300.473243,662,663CommonForm 4 ↗
Lazarus KrikorianSVP & Chief Accounting Officer2026-09-01D985326321,080CommonForm 4 ↗
Lon R. GreenbergDirector2026-09-16D1,280321411,264CommonForm 4 ↗
Lazarus KrikorianSVP & Chief Accounting Officer2026-10-01D986303298,935CommonForm 4 ↗
Robert E. SanchezDirector2026-10-01A275——CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

03

Grants of plan-based awards — fiscal year 2025

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
Steven CollisRSU2024-11-20——9,869—$2,400,140
Robert MauchPSU2024-11-2014,80329,606—68,0947,200,179
Elizabeth CampbellRSU2024-11-20——4,770—1,160,064
Elizabeth CampbellPSU2024-11-203,5787,155—16,4571,740,096
Silvana BattagliaPSU2024-11-202,0984,195—9,6491,020,224
Robert MauchRSU2024-11-20——19,737—4,800,039
James ClearyPSU2024-11-204,6889,375—21,5632,280,000
Steven CollisPSU2024-11-207,40214,803—34,0473,600,090
James ClearyRSU2024-11-20——6,250—1,520,000
Silvana BattagliaRSU2024-11-20——2,797—680,230
03b

Vehicle mix — grant-date fair value by award type

Named executive officerTime-vested (RSU)Performance-vested (PSU)Options / SARs% performance-vested
Steven Collis$2,400,140$3,600,090$060.0%
Robert Mauch4,800,0397,200,179060.0%
Elizabeth Campbell1,160,0641,740,096060.0%
Silvana Battaglia680,2301,020,224060.0%
James Cleary1,520,0002,280,000060.0%

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

04

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Robert MauchPSU68,094—$21,281,418
Elizabeth CampbellRSU3,660—1,143,860
James ClearyPSU21,563—6,739,084
Elizabeth CampbellPSU18,936—5,918,068
Steven CollisRSU10,536—3,292,816
Silvana BattagliaRSU8,415—2,629,940
Robert MauchRSU4,215—1,317,314
James ClearyRSU6,043—1,888,619
Silvana BattagliaRSU2,169—677,878
James ClearyPSU25,247—7,890,445
James ClearyRSU12,623—3,945,066
Silvana BattagliaRSU2,797—874,146
Elizabeth CampbellRSU12,623—3,945,066
Elizabeth CampbellPSU35,393—11,061,374
Elizabeth CampbellRSU23,076—7,211,942
Silvana BattagliaPSU20,871—6,522,814
Silvana BattagliaRSU14,646—4,577,314
Robert MauchPSU42,076—13,150,012
James ClearyOption45,15486.09—
Robert MauchOption18,81486.09—
Steven CollisPSU87,658—27,395,755
Steven CollisOption58,69986.09—
Steven CollisPSU34,047—10,640,709
Robert MauchRSU18,948—5,921,818
Steven CollisRSU16,939—5,293,946
Elizabeth CampbellPSU16,457—5,143,306
Silvana BattagliaPSU11,222—3,507,212
Silvana BattagliaPSU9,649—3,015,602
Steven CollisRSU9,474—2,960,909
Robert MauchRSU8,131—2,541,181
James ClearyRSU4,879—1,524,834
Elizabeth CampbellRSU4,770—1,490,768
James ClearyRSU2,951—922,276
Elizabeth CampbellRSU2,023—632,248
Silvana BattagliaRSU1,265—395,350
05

Incentive-plan design — the Compensation Discussion & Analysis

The Compensation Committee supports a compensation philosophy for our NEOs that: [bullet points follow] We emphasize a compensation philosophy that rewards our executive officers when they deliver targeted financial results and subjects a significant portion of their compensation to risk if they do not.

CEO STI target (% of salary)175%
CEO LTI target (% of salary)—
Independent consultantPearl Meyer & Partners
Clawback policyTrue
Anti-hedgingTrue
Anti-pledgingTrue
06

Say-on-pay — recent advisory votes

Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20262026-03-05156,852,21411,422,390427,40792.98%Passed
20252025-03-06156,885,71312,269,867187,48692.75%Passed
20242024-03-12164,272,54610,905,767533,14993.77%Passed
20232023-03-09167,879,5117,418,048503,11695.77%Passed
20222022-03-10174,566,8038,079,219391,81695.58%Passed
20212021-03-1191,818,54085,990,782494,90251.64%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.

Say-on-pay — history, company's computation

Meeting yearMeeting dateApproval — company's computation
20262026-03-0592.98%a
20252025-03-0692.75%b
20242024-03-1293.77%c

a. Approved under the standard stated in the filing — “2 Advisory vote to approve the fiscal 2025 compensation of Cencora's named executive officers For Majority of shares present and entitled to vote on the matter (3) Counted "against" No effect”.

b. Approved under the standard stated in the filing — “Abstentions and broker non-votes have no effect in determining if a majority of the votes have been cast in favor of a director.”.

c. Approved under the standard stated in the filing — “Abstentions and broker non-votes have no effect in determining if a majority of the votes have been cast in favor of a director.”.

Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

07

CEO pay ratio

Ratio (CEO : median employee)198 : 1
CEO total compensation$18,256,227
Median employee compensation$92,438
08

Director compensation — fiscal year 2025

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Frank K. ClyburnIndependent · Compliance and Risk · Finance$110,000$286,436$0—$0$396,436
Redonda G. Miller, M.DIndependent · Compliance and Risk (Chair) · Governance, Sustainability and Corporate Responsibility · Special Litigation185,000200,2250—0385,225
Werner BaumannIndependent · Audit (Chair) · Compensation and Succession Planning · Executive · Special Litigation (Chair)182,870200,2250—0383,095
D. Mark DurcanIndependent · Board Chair · Executive (Chair)125,000250,2170—0375,217
Lauren M. TylerIndependent · Audit · Governance, Sustainability and Corporate Responsibility · Special Litigation160,715200,2250—0360,940
Dennis M. NallyIndependent · Audit · Compensation and Succession Planning (Chair)145,481200,2250—0345,706
Lorence H. Kim, M.DIndependent · Compensation and Succession Planning · Executive · Finance (Chair)130,000200,2250—0330,225
Lon R. GreenbergIndependent · Compliance and Risk · Executive · Finance · Governance, Sustainability and Corporate Responsibility (Chair)130,000200,2250—0330,225
Lori J. RyerkerkIndependent · Newly elected40,000152,3900—0192,390
Kathleen W. HyleIndependent · Not standing for re-election · Departed during FY60,000—0—060,000
Richard W. GochnauerIndependent · Not standing for re-election · Departed during FY50,000—0—050,000
Robert P. MauchEmployee director · Executive000—00
Steven H. CollisEmployee director · Departed during FY000—00
Ornella BarraNot independent · Departed during FY000—00
Ellen G. CooperIndependent · Newly elected000—00
09

Board fee structure and ownership guideline

Annual cash retainer$125,000
Annual equity retainer$250,000
Per board meeting fee—
Committee chair fees (audit / comp / nom-gov)25,000 / 20,000 / 20,000
Stock ownership guideline5 times annual cash retainer
09b

Total cost of the board

ComponentFY2025
Cash retainers and fees$1,319,066
Equity awards (grant-date value)$1,890,393
All other compensation$0
Total cost of the board$3,209,459

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10

Disclosed peer group — fiscal year 2025

The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.

10a

Peer reciprocity

Of the companies Cencora names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.

Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Cencora.

10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Eli Lilly and Company2025David Ricks$1,700,000$23,325,000$0$6,485,500$36,698,337
2IQVIA Holdings Inc.2025Ari Bousbib1,800,00015,749,9574,528,3174,966,12728,128,245
3FedEx Corporation2026Rajesh Subramaniam1,550,0006,731,3643,715,06210,593,50027,554,018
4HCA Healthcare, Inc.2025Samuel Hazen1,577,8158,474,5438,514,0905,416,73226,456,606
5McKesson Corporation2026Brian Tyler1,591,66717,201,20204,456,66824,213,044
6United Parcel Service, Inc.2025Carol Tomé1,509,71317,550,5461,358,7542,264,56922,878,788
7The Cigna Group2025David Cordani1,600,00013,929,1613,400,0193,200,00022,866,134
8Cardinal Health, Inc.2026Jason Hollar1,500,00016,259,91804,278,75022,574,349
9CVS Health Corporation2025J. David Joyner1,500,00014,499,93104,695,90021,214,084
10Humana Inc.2025James Rechtin1,348,55813,868,14103,034,74018,757,075
11Labcorp Holdings Inc.2025Adam Schechter1,435,00011,400,4632,754,5822,062,09518,339,913
12Cencora2025Robert Mauch1,350,00012,000,21804,283,21318,256,227
13Sysco Corporation2026Kevin Hourican1,435,53810,391,7592,579,9862,905,60217,899,369
14Quest Diagnostics Incorporated2025James Davis1,250,0008,762,8612,999,8732,205,84415,498,479
15Viatris Inc.2025Scott Smith1,448,65410,150,01302,973,66015,273,331
16The Kroger Co.2025Ronald L. Sargent3,975,80610,000,077——14,037,608
17Walgreens Boots Alliance, Inc.2024Timothy Wentworth1,290,38511,600,7440013,282,800
18Henry Schein, Inc.2025Stanley Bergman1,707,0007,764,80002,289,25112,013,915
19Target Corporation2025Michael Fiddelke1,065,3857,853,2530300,8829,598,071

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

10c

Incentive design against the same peers

CompanyAnnual incentive payoutLong-term vehicle mixPSU measures include TSRCompensation consultant
Cencora181.3%PSU 60 · RSU 40Yes — Relative TSRPearl Meyer & Partners
Cardinal Health, Inc.not disclosedPSU 60 · RSU 40Yes — Relative TSR modifierKorn Ferry
CVS Health Corporation156.5%PSU 60 · RSU 20 · Options 20Yes — rTSR ModifierKorn Ferry
Eli Lilly and Company218%PSU 100NoFW Cook
FedEx Corporation112.5%not disclosedYes — Relative TSR (FY24-FY26 LTI Cash Plan)Meridian Compensation Partners, LLC
HCA Healthcare, Inc.195.78%SAR 50 · PSU 50NoSemler Brossy
Henry Schein, Inc.89.3%PSU 65 · RSU 35NoPearl Meyer
Humana Inc.112%PSU 60 · RSU 40Yes — Relative TSRFarient Advisors, LLC
IQVIA Holdings Inc.not disclosedPSU 75 · Options 25YesMeridian Compensation Partners, LLC
Labcorp Holdings Inc.95.8%PSU 60 · RSU 20 · Options 20Yes — RELATIVE TSR MODIFIERFW Cook
McKesson Corporation140%PSU 60 · RSU 40Yes — Total Shareholder Return (TSR) relative to comparator groupKorn Ferry
Quest Diagnostics Incorporated113.9%PSU 50 · RSU 25 · Options 25Yes — Relative TSRSemler Brossy
Sysco Corporation115.66%PSU 50 · RSU 30 · Option 20NoSemler Brossy
Target Corporationnot disclosedPSU 60 · PBRSU 40NoSemler Brossy
The Cigna Group100%PSU 60 · RSU 20 · Options 20NoPay Governance
The Kroger Co.93.84%not disclosedYes — Value creation (iTSR)Korn Ferry; Meridian Compensation Partners, LLC
United Parcel Service, Inc.75%PSU 93 · Options 7Yes — Relative Total Shareowner Return (RTSR)FW Cook
Viatris Inc.136.72%PSU 65 · RSU 35NoMeridian Compensation Partners, LLC
Walgreens Boots Alliance, Inc.not disclosedRSU 100not disclosedMercer

Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.

10d

Frequently asked questions

Who was the highest-paid executive at Cencora in fiscal 2025?
As disclosed, Robert Mauch (President and Chief Executive Officer) was the highest-paid executive at Cencora in fiscal 2025, with total compensation of $18,256,227.
How does Cencora's chief executive pay compare to its disclosed peer group?
As disclosed, Robert Mauch's total compensation ranked at the 39th percentile of Cencora's disclosed peer group.
What is Cencora's CEO-to-median employee pay ratio?
As disclosed, Cencora's CEO-to-median employee pay ratio was 198:1.
How did shareholders vote on Cencora's executive compensation?
As disclosed, 92.98% of shareholders supported Cencora's executive compensation in the latest say-on-pay vote.
How much does Cencora spend in total on board compensation for fiscal 2025?
As disclosed, Cencora reported total board compensation of $3,209,459 for fiscal 2025.

Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, Robert MauchDEF 14A2026-01-220001628280-26-003061Section “Summary compensation table”. As printed: 18,256,227. Filing ↗machine: r2 · c18 · span 1212336–1212346
2Section 01, Steven CollisDEF 14A2026-01-220001628280-26-003061Section “Summary compensation table”. As printed: 9,680,235. Filing ↗machine: r5 · c18 · span 1218052–1218061
3Section 01, James ClearyDEF 14A2026-01-220001628280-26-003061Section “Summary compensation table”. As printed: 6,521,727. Filing ↗machine: r8 · c18 · span 1224105–1224114
4Section 01, Elizabeth CampbellDEF 14A2026-01-220001628280-26-003061Section “Summary compensation table”. As printed: 5,176,668. Filing ↗machine: r12 · c18 · span 1230101–1230110
5Section 01, Silvana BattagliaDEF 14A2026-01-220001628280-26-003061Section “Summary compensation table”. As printed: 3,663,393. Filing ↗machine: r15 · c18 · span 1236177–1236186
6Section 03, Steven Collis RSUDEF 14A1900-01-010001628280-26-003061Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1296257–1296266
7Section 03, Robert Mauch PSUDEF 14A1900-01-010001628280-26-003061Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1289632–1289641
8Section 03, Elizabeth Campbell RSUDEF 14A1900-01-010001628280-26-003061Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1315772–1315781
9Section 03, Elizabeth Campbell PSUDEF 14A1900-01-010001628280-26-003061Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1319231–1319240
10Section 03, Silvana Battaglia PSUDEF 14A1900-01-010001628280-26-003061Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1328845–1328854
11Section 03, Robert Mauch RSUDEF 14A1900-01-010001628280-26-003061Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1286922–1286931
12Section 03, James Cleary PSUDEF 14A1900-01-010001628280-26-003061Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1309144–1309153
13Section 03, Steven Collis PSUDEF 14A1900-01-010001628280-26-003061Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1299437–1299446
14Section 03, James Cleary RSUDEF 14A1900-01-010001628280-26-003061Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1306086–1306095
15Section 03, Silvana Battaglia RSUDEF 14A1900-01-010001628280-26-003061Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1325914–1325921
16Section 07, pay ratioDEF 14A2026-01-220001628280-26-003061Section “CEO Pay Ratio”. As printed: 198 : 1. Filing ↗machine: span 1600983–1600988
17Section 08, Frank K. ClyburnDEF 14A2026-01-220001628280-26-003061Section “Director Compensation”. As printed: 396,436. Filing ↗machine: t123 · r4 · c5 · span 790287–790502
18Section 08, Redonda G. Miller, M.DDEF 14A2026-01-220001628280-26-003061Section “Director Compensation”. As printed: 385,225. Filing ↗machine: t123 · r10 · c5 · span 798149–798364
19Section 08, Werner BaumannDEF 14A2026-01-220001628280-26-003061Section “Director Compensation”. As printed: 383,095. Filing ↗machine: t123 · r3 · c5 · span 789114–789354
20Section 08, D. Mark DurcanDEF 14A2026-01-220001628280-26-003061Section “Director Compensation”. As printed: 375,217. Filing ↗machine: t123 · r5 · c5 · span 791523–791763
21Section 08, Lauren M. TylerDEF 14A2026-01-220001628280-26-003061Section “Director Compensation”. As printed: 360,940. Filing ↗machine: t123 · r13 · c5 · span 802268–802542
22Section 08, Dennis M. NallyDEF 14A2026-01-220001628280-26-003061Section “Director Compensation”. As printed: 345,706. Filing ↗machine: t123 · r11 · c5 · span 799701–799941
23Section 08, Lorence H. Kim, M.DDEF 14A2026-01-220001628280-26-003061Section “Director Compensation”. As printed: 330,225. Filing ↗machine: t123 · r9 · c5 · span 796969–797209
24Section 08, Lon R. GreenbergDEF 14A2026-01-220001628280-26-003061Section “Director Compensation”. As printed: 330,225. Filing ↗machine: t123 · r7 · c5 · span 794241–794481
25Section 08, Lori J. RyerkerkDEF 14A2026-01-220001628280-26-003061Section “Director Compensation”. As printed: 192,390. Filing ↗machine: t123 · r12 · c5 · span 800862–801077
26Section 08, Kathleen W. HyleDEF 14A2026-01-220001628280-26-003061Section “Director Compensation”. As printed: 60,000. Filing ↗machine: t123 · r8 · c1 · span 795216–795345
27Section 08, Richard W. GochnauerDEF 14A2026-01-220001628280-26-003061Section “Director Compensation”. As printed: 50,000. Filing ↗machine: t123 · r6 · c1 · span 792502–792631
28Section 08, Robert P. MauchDEF 14A2026-01-220001628280-26-003061Section “Director Compensation”. As printed: 0. Filing ↗
29Section 08, Steven H. CollisDEF 14A2026-01-220001628280-26-003061Section “Director Compensation”. As printed: 0. Filing ↗
30Section 08, Ornella BarraDEF 14A2026-01-220001628280-26-003061Section “Director Compensation”. As printed: 0. Filing ↗machine: t123 · r2 · c3 · span 787603–787604
31Section 08, Ellen G. CooperDEF 14A2026-01-220001628280-26-003061Section “Director Compensation”. As printed: 0. Filing ↗
32Section 02, Lauren M. Tyler 2026-01-30Form 42026-03-090001765744-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
33Section 02, Dennis M. Nally 2026-01-30Form 42026-03-090001685596-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
34Section 02, Ellen G. Cooper 2026-01-30Form 42026-03-090001555614-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
35Section 02, Ellen G. Cooper 2026-01-30Form 42026-03-090001555614-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
36Section 02, Robert P. Mauch 2026-02-18Form 42026-02-200001633897-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
37Section 02, Robert P. Mauch 2026-02-20Form 42026-02-240001633897-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
38Section 02, Robert P. Mauch 2026-02-20Form 42026-02-240001633897-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
39Section 02, Robert P. Mauch 2026-02-20Form 42026-02-240001633897-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
40Section 02, Lori J. Ryerkerk 2026-03-05Form 42026-03-090001449522-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
41Section 02, Redonda Miller 2026-03-05Form 42026-03-090001891346-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
42Section 02, D. Mark Durcan 2026-03-05Form 42026-03-090001202358-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
43Section 02, Werner Baumann 2026-03-05Form 42026-03-090001986505-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
44Section 02, Lauren M. Tyler 2026-03-05Form 42026-03-090001765744-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
45Section 02, Dennis M. Nally 2026-03-05Form 42026-03-090001685596-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
46Section 02, Ellen G. Cooper 2026-03-05Form 42026-03-090001555614-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
47Section 02, Frank K. Clyburn 2026-03-05Form 42026-03-090001763963-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
48Section 02, Lorence H. Kim 2026-03-05Form 42026-03-090001643746-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
49Section 02, Lon R. Greenberg 2026-03-05Form 42026-03-090001234234-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
50Section 02, James Cleary 2026-03-11Form 42026-03-130001333281-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
51Section 02, Elizabeth Campbell 2026-03-11Form 42026-03-130001882641-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
52Section 02, Silvana Battaglia 2026-03-11Form 42026-03-130001774724-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
53Section 02, Silvana Battaglia 2026-03-11Form 42026-03-130001774724-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
54Section 02, Elizabeth Campbell 2026-03-11Form 42026-03-130001882641-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
55Section 02, Silvana Battaglia 2026-03-11Form 42026-03-130001774724-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
56Section 02, James Cleary 2026-03-11Form 42026-03-130001333281-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
57Section 02, James Cleary 2026-03-11Form 42026-03-130001333281-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
58Section 02, Elizabeth Campbell 2026-03-11Form 42026-03-130001882641-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
59Section 02, Lazarus Krikorian 2026-04-01Form 42026-04-020001627534-26-000002Insider equity transaction reported since the proxy statement. Filing ↗
60Section 02, Dennis M. Nally 2026-05-01Form 42026-05-050001685596-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
61Section 02, Lauren M. Tyler 2026-05-01Form 42026-05-050001765744-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
62Section 02, Ellen G. Cooper 2026-05-01Form 42026-05-050001555614-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
63Section 02, D. Mark Durcan 2026-05-28Form 42026-05-280001202358-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
64Section 02, D. Mark Durcan 2026-06-18Form 42026-06-220001202358-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
65Section 02, Lauren M. Tyler 2026-06-22Form 42026-06-240001765744-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
66Section 02, Eva C. Boratto 2026-06-29Form 42026-06-300001580827-26-000005Insider equity transaction reported since the proxy statement. Filing ↗
67Section 02, Elizabeth Campbell 2026-06-30Form 42026-07-070001882641-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
68Section 02, Silvana Battaglia 2026-06-30Form 42026-07-070001774724-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
69Section 02, Ellen G. Cooper 2026-07-31Form 42026-08-040001555614-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
70Section 02, Dennis M. Nally 2026-07-31Form 42026-08-040001685596-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
71Section 02, Lauren M. Tyler 2026-07-31Form 42026-08-040001765744-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
72Section 02, Elizabeth Campbell 2026-08-24Form 42026-08-250001882641-26-000008Insider equity transaction reported since the proxy statement. Filing ↗
73Section 02, Lazarus Krikorian 2026-09-01Form 42026-09-020001627534-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
74Section 02, Lon R. Greenberg 2026-09-16Form 42026-09-170001234234-26-000004Insider equity transaction reported since the proxy statement. Filing ↗
75Section 02, Lazarus Krikorian 2026-10-01Form 42026-10-050001627534-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
76Section 02, Robert E. Sanchez 2026-10-01Form 42026-10-050001216931-26-000012Insider equity transaction reported since the proxy statement. Filing ↗
77Section 06, 2026 voteForm 8-K2026-03-060001140859-26-000014Item 5.07 · say-on-pay result. As reported: 92.98% (votes for as printed: 156,852,214). Filing ↗
78Section 06, 2025 voteForm 8-K2025-03-100001104659-25-022205Item 5.07 · say-on-pay result. As reported: 92.75% (votes for as printed: 156,885,713). Filing ↗
79Section 06, 2024 voteForm 8-K2024-03-150001104659-24-035043Item 5.07 · say-on-pay result. As reported: 93.77% (votes for as printed: 164,272,546). Filing ↗
80Section 01 trend, Δ column (computed)Computed——Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1)
81Section 03b vehicle mix (computed)Computed——RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio
82Section 09b board cost (computed)Computed——Cash 1,319,066 + equity 1,890,393 + all other 0 = 3,209,459, summed across the director compensation table rows.machine: formula: Σ = 3,209,459
83Eli Lilly and Company, Section 10b CEO totalDEF 14A2026-03-200000059478-26-000029CEO total compensation as printed in Eli Lilly and Company's own proxy. As printed: 36,698,337. Filing ↗machine: t92 · r2 · c20 · span 925013–925024
84IQVIA Holdings Inc., Section 10b CEO totalDEF 14A2026-02-270001628280-26-012892CEO total compensation as printed in IQVIA Holdings Inc.'s own proxy. As printed: 28,128,245. Filing ↗machine: t232 · r4 · c10 · span 1613956–1613966
85FedEx Corporation, Section 10b CEO totalDEF 14A2026-08-170001104659-26-097836CEO total compensation as printed in FedEx Corporation's own proxy. As printed: 27,554,018. Filing ↗machine: r1 · c54 · span 1409491–1409501
86HCA Healthcare, Inc., Section 10b CEO totalDEF 14A2026-03-130001193125-26-106142CEO total compensation as printed in HCA Healthcare, Inc.'s own proxy. As printed: 26,456,606. Filing ↗machine: span 784078–784088
87McKesson Corporation, Section 10b CEO totalDEF 14A2026-06-120000927653-26-000169CEO total compensation as printed in McKesson Corporation's own proxy. As printed: 24,213,044. Filing ↗machine: r2 · c21 · span 1260172–1260182
88United Parcel Service, Inc., Section 10b CEO totalDEF 14A2026-03-190001628280-26-019856CEO total compensation as printed in United Parcel Service, Inc.'s own proxy. As printed: 22,878,788. Filing ↗machine: r2 · c27 · span 899122–899132
89The Cigna Group, Section 10b CEO totalDEF 14A2026-03-130001739940-26-000023CEO total compensation as printed in The Cigna Group's own proxy. As printed: 22,866,134. Filing ↗machine: t303 · r3 · c16 · span 1360729–1360739
90Cardinal Health, Inc., Section 10b CEO totalDEF 14A2026-09-210001308179-26-000402CEO total compensation as printed in Cardinal Health, Inc.'s own proxy. As printed: 22,574,349. Filing ↗machine: r2 · c21 · span 1230025–1230035
91CVS Health Corporation, Section 10b CEO totalDEF 14A2026-04-030001308179-26-000201CEO total compensation as printed in CVS Health Corporation's own proxy. As printed: 21,214,084. Filing ↗machine: r1 · c18 · span 969864–969874
92Humana Inc., Section 10b CEO totalDEF 14A2026-03-060001104659-26-024799CEO total compensation as printed in Humana Inc.'s own proxy. As printed: 18,757,075. Filing ↗machine: t157 · r1 · c63 · span 1938706–1938716
93Labcorp Holdings Inc., Section 10b CEO totalDEF 14A2026-04-100001193125-26-150752CEO total compensation as printed in Labcorp Holdings Inc.'s own proxy. As printed: 18,339,913. Filing ↗machine: t153 · r3 · c22 · span 3147696–3147706
94Cencora (subject), Section 10b CEO totalDEF 14A2026-01-220001628280-26-003061CEO total compensation as printed in Cencora's own proxy. As printed: 18,256,227. Filing ↗machine: r2 · c18 · span 1212336–1212346
95Sysco Corporation, Section 10b CEO totalDEF 14A2026-10-010000096021-26-000037CEO total compensation as printed in Sysco Corporation's own proxy. As printed: 17,899,369. Filing ↗machine: r2 · c9 · span 2096793–2096803
96Quest Diagnostics Incorporated, Section 10b CEO totalDEF 14A2026-04-060001140361-26-013356CEO total compensation as printed in Quest Diagnostics Incorporated's own proxy. As printed: 15,498,479. Filing ↗machine: r2 · c17 · span 699327–699337
97Viatris Inc., Section 10b CEO totalDEF 14A2026-04-020001140361-26-013002CEO total compensation as printed in Viatris Inc.'s own proxy. As printed: 15,273,331. Filing ↗machine: r2 · c28 · span 1344008–1344018
98The Kroger Co., Section 10b CEO totalDEF 14A2026-05-130001104659-26-060250CEO total compensation as printed in The Kroger Co.'s own proxy. As printed: 14,037,608. Filing ↗machine: t229 · r1 · c9 · span 692555–692565
99Walgreens Boots Alliance, Inc., Section 10b CEO totalDEF 14A2024-12-130001558370-24-016214CEO total compensation as printed in Walgreens Boots Alliance, Inc.'s own proxy. As printed: 13,282,800. Filing ↗machine: r11 · c18 · span 2265448–2265458
100Henry Schein, Inc., Section 10b CEO totalDEF 14A2026-04-080001193125-26-146317CEO total compensation as printed in Henry Schein, Inc.'s own proxy. As printed: 12,013,915. Filing ↗machine: t221 · r3 · c35 · span 671366–671376
101Target Corporation, Section 10b CEO totalDEF 14A2026-04-270001628280-26-027508CEO total compensation as printed in Target Corporation's own proxy. As printed: 9,598,071. Filing ↗machine: r7 · c8 · span 2799507–2799517
102Section 10a, Eli Lilly and Company reciprocityDEF 14A—0000059478-26-000029Eli Lilly and Company's most recent proxy was read; its disclosed peer group does not include Cencora. Filing ↗
103Section 10a, Cardinal Health, Inc. reciprocityDEF 14A—0001308179-26-000402Cardinal Health, Inc. names Cencora in its own disclosed peer group (read from its most recent proxy). Filing ↗
104Section 10a, Henry Schein, Inc. reciprocityDEF 14A—0001193125-26-146317Henry Schein, Inc. names Cencora in its own disclosed peer group (read from its most recent proxy). Filing ↗
105Section 10a, McKesson Corporation reciprocityDEF 14A—0000927653-26-000169McKesson Corporation names Cencora in its own disclosed peer group (read from its most recent proxy). Filing ↗
106Section 10a, Target Corporation reciprocityDEF 14A—0001628280-26-027508Target Corporation's most recent proxy was read; its disclosed peer group does not include Cencora. Filing ↗
107Section 10a, The Cigna Group reciprocityDEF 14A—0001739940-26-000023The Cigna Group names Cencora in its own disclosed peer group (read from its most recent proxy). Filing ↗
108Section 10a, IQVIA Holdings Inc. reciprocityDEF 14A—0001628280-26-012892IQVIA Holdings Inc.'s most recent proxy was read; its disclosed peer group does not include Cencora. Filing ↗
109Section 10a, Viatris Inc. reciprocityDEF 14A—0001140361-26-013002Viatris Inc.'s most recent proxy was read; its disclosed peer group does not include Cencora. Filing ↗
110Section 10a, HCA Healthcare, Inc. reciprocityDEF 14A—0001193125-26-106142HCA Healthcare, Inc. names Cencora in its own disclosed peer group (read from its most recent proxy). Filing ↗
111Section 10a, Sysco Corporation reciprocityDEF 14A—0000096021-26-000037Sysco Corporation's most recent proxy was read; its disclosed peer group does not include Cencora. Filing ↗
112Section 10a, Quest Diagnostics Incorporated reciprocityDEF 14A—0001140361-26-013356Quest Diagnostics Incorporated's most recent proxy was read; its disclosed peer group does not include Cencora. Filing ↗
113Section 10a, United Parcel Service, Inc. reciprocityDEF 14A—0001628280-26-019856United Parcel Service, Inc.'s most recent proxy was read; its disclosed peer group does not include Cencora. Filing ↗
114Section 10a, Humana Inc. reciprocityDEF 14A—0001104659-26-024799Humana Inc. names Cencora in its own disclosed peer group (read from its most recent proxy). Filing ↗
115Section 10a, Labcorp Holdings Inc. reciprocityDEF 14A—0001193125-26-150752Labcorp Holdings Inc.'s most recent proxy was read; its disclosed peer group does not include Cencora. Filing ↗
116Section 10a, Walgreens Boots Alliance, Inc. reciprocityDEF 14A—0001558370-24-016214Walgreens Boots Alliance, Inc.'s most recent proxy was read; its disclosed peer group does not include Cencora. Filing ↗

The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.

You'll confirm on The Pay Desk's sign-up page.